Methods. In total, 159 procedures from 5 academic rheumatology centers were evaluated. Hematoxylin and eosin-stained, paraffin-embedded synovial tissue sections from patients with inflammatory arthritis were assessed in order to determine the proportion of graded synovial fragments, total area of graded synovial tissue, and synovitis score per procedure. RNA quantity (lg of RNA) and quality (RNA integrity number) per procedure were also assessed in the synovial samples.
US-P&F, 11 US-NB, and 13 BN biopsies), 41 of the 159 procedures performed on small joints at baseline (11 US-P&F, 20 US-NB, and 10 BN biopsies), and 34 sequential biopsy procedures were evaluated. Compared to all other techniques evaluated in the small and large joints, fewer small joint BN biopsies and a significantly lower proportion of large joint BN biopsies yielded graded synovial tissue. No significant difference in either the proportion of graded tissue samples or total graded synovial tissue area between the US-NB and arthroscopic large joint procedures was demonstrated. Among the sequential biopsy procedures evaluated (small joint US-NB, large joint arthroscopy, US-P&F biopsy, and BN biopsy), no significant difference in the proportion of graded synovial tissue or total graded synovial tissue area was demonstrated. All procedures yielded RNA of significant quality and quantity for subsequent transcriptomic analysis.
Conclusion. These data support the integration of US-guided methods along with arthroscopic biopsy for clinical trial protocols in which sequential sampling of synovium from the large and small joints is needed for both histologic and molecular analysis. BN biopsy may be considered if graded synovial tissue is not required for subsequent analyses.
The outcome for patients diagnosed as having rheumatoid arthritis (RA) has improved dramatically in the past 2 decades (1), although the ability to induce sustained disease remissions on an individual patient level remains limited. Synovial tissue offers a target not only to dissect the pathogenesis of RA but also to identify novel targeted therapies and biomarkers of prognosis/therapeutic response (2) (3) (4) (5) (6) . Currently, acquisition of synovial tissue utilizing an arthroscopic approach is recommended in 1 clinical trials, based on validation studies in which synovial tissue quality and quantity have been evaluated (7) and based on acceptability to patients and observations of sufficient safety (8) . However, an arthroscopic approach, in general, limits sampling to the large joints of patients being evaluated in highly specialized academic centers (8) .
Alternative techniques to direct synovial tissue sampling, such as blind needle (BN) biopsy and, more recently, ultrasound (US)-guided procedures, have also been adopted by investigators. The latter procedures are particularly attractive-being minimally invasive, applicable to both large and small joints, relatively inexpensive to perform, and technically simple-and thus offer the potential to accelerate the accumulated knowledge of synovial diagnostic and prognostic biomarkers via facilitation of wider access to synovial samples (7, 9) . Two principal techniques utilizing US have been described, a US-guided portal and forceps (P&F) approach (10) and a more recent adaptation involving a guillotine-style biopsy needle (US-guided needle biopsy [NB]) (11) .
Despite the fact that comparative data evaluating the performance of minimally invasive biopsy techniques against the performance of arthroscopy have been largely lacking, it remains an important research objective (12) . Therefore, the aim of this study was to evaluate whether significant differences in the quality and quantity of synovial sampling could be demonstrated between arthroscopic, BN, US-P&F, and US-NB synovial biopsy procedures in patients with inflammatory arthritis.
PATIENTS AND METHODS
Cohort. The present study was a multicenter retrospective analysis. In order to identify centers with suitable patient cohorts, the study protocol was presented to the European Synovitis Study Group at the annual European League Against Rheumatism meetings between 2014 and 2017, and members were invited to participate. In order to standardize synovial tissue quality assessments, participating centers were required to have retained paraffin-embedded synovial samples from patients with inflammatory arthritis. In total, 5 international academic rheumatology centers provided synovial sample cohorts: Barts and the London School of Medicine in the UK (US-NB procedures), IRCCS Policlinico San Matteo Foundation/University of Pavia in Italy (US-P&F procedures), the University of Birmingham in the UK (US-P&F procedures), the Repatriation General Hospital in Adelaide, Australia (arthroscopy procedures), and the Lisbon Academic Medical Centre in Portugal (US-NB, arthroscopic, and BN procedures).
Baseline data on the patients' demographic and clinical characteristics, including diagnosis, disease duration, disease activity (measured according to the original 44-joint Disease Activity Score [DAS44] or modified 28-joint Disease Activity Score [DAS28] [13] ), seropositivity for rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs), and presence of erosive disease (in the hands and feet) were collected from the recruited patients within each cohort. Biopsy procedures were segregated for analysis into large joint procedures (of the knee or ankle) and small joint procedures (of the wrist, metacarpophalangeal [MCP] joint, or proximal interphalangeal [PIP] joint), and further separated into the biopsy time points of baseline and 6-months follow-up. All procedures were performed after the patients had provided their written informed consent and local ethics approval had been obtained at each site.
Synovial sampling techniques. All procedures retrieved a minimum of 6 synovial samples for paraffin embedding, and a minimum of 6 samples were collected for subsequent RNA extraction. Sequential biopsies were performed on the same joint at baseline and at 6-months follow-up.
Procedures. Arthroscopic procedure. Arthroscopic synovial biopsies were performed on patients after they had been placed under general anesthesia. A small-bore arthroscope (2.7-mm; Dyonics) under direct vision was used for this procedure, and previously described standard approaches were applied (14) ( Figure 1A) .
US-guided P&F biopsy. US-P&F biopsies were performed in a manner as previously described (10) on the large joints (knee or ankle) and small joints. The skin, subcutaneous tissue, and synovial space were infiltrated after patients were administered local anesthetic, and a 14-gauge needle was inserted into the joint under direct US vision. A 6F percutaneous sheath introducer (Cordis) was inserted into the joint under US guidance and following a flexible wire. The flexible wire was then removed, and a rigid Hartmann's ear forceps (Medicon) or flexible forceps (Tonatarra) was introduced to retrieve synovium ( Figure 1B) . BN biopsy. All BN biopsies were performed in the knee or wrist joint using a Parker-Pearson needle (Dixons), as previously described (15, 16) . Following application of local anesthesia to the soft tissue, a small skin incision was made and the biopsy trocar (14-gauge), with the obturator in place, was inserted into the joint ( Figure 1C) . The obturator was then removed, and the inner needle was attached to a Luer-Lock syringe (Normax) and inserted through the trocar to retrieve synovium.
US-guided NB. US-guided NB procedures were performed, as previously described, (11) both on the large joints (suprapatellar pouch) and small joints. Briefly, local anesthetic was injected into the soft tissue up to the joint capsule and into the joint space. A Quick-Core biopsy needle (16/14-gauge; Cook Medical) was then placed within the joint capsule ( Figure 1D ) to retrieve synovium.
Synovial histopathologic assessment. Four 3-lm-thick, sequentially cut, paraffin-embedded sections of synovial tissue previously retrieved from each biopsy procedure were sent for histopathologic analysis at Barts and the London School of Medicine. Hematoxylin and eosin-stained slides were examined, and the following parameters were determined: 1) number of graded synovial tissue fragments (lining layer of at least 10 continuous cells in at least one tissue fragment); 2) total number of synovial tissue fragments; 3) total area of graded synovial tissue, determined using CellSens Dimensions software (version 1.12); and 4) degree of synovitis, determined using a previously validated semiquantitative scoring system for the severity of synovitis (scale 0-9) (17). In addition, using previously published immunohistochemical staining protocols (18) to identify CD20+ B cells, CD3+ Tcells, CD68+ sublining (SL) macrophages, and CD138+ plasma cells, sequential sections were also assessed semiquantitatively for the degree of immune cell infiltration (grading scale 0-4) (18) and for the presence and grade of CD20+ B cell aggregates (utilizing a method as previously described [19] RNA extraction. In order to identify whether significant differences in the quality and quantity of RNA were present between the synovial biopsy techniques, participating centers retaining tissue for RNA extraction were also asked to provide data on extraction technique, the total weight of RNA, and the RNA integrity (RNA integrity number [RIN] 
RESULTS
Patients and biopsies. Among the 5 participating international academic rheumatology centers, a total of 159 procedures were evaluated. Among these, 125 synovial samples were retrieved by biopsy at baseline, and a further 34 samples were retrieved from patients who underwent paired sequential biopsy procedures, both at baseline and at 6 months ( Table 1) .
In total, 84 procedures were performed on the large joints and 41 on the small joints at baseline. Of the 84 large joint procedures performed, 25 were knee arthroscopies, 35 were US-P&F (3 of the ankle and 32 of the knee), 11 were US-NB of the knee, and 13 were BN biopsy of the knee. Of the 41 small joint procedures performed, 11 were US-P&F biopsies of the MCP joint, 20 were US-NB biopsies (15 of the wrist, 4 of the MCP joint, and 1 of and by chi-square test for evaluation of significant differences in proportions. US-NB = ultrasound-guided needle biopsy; US-P&F = ultrasoundguided portal and forceps; RA = rheumatoid arthritis; PsA = psoriatic arthritis; SpA = spondyloarthritis; JIA = juvenile idiopathic arthritis; RF = rheumatoid factor; ACPAs = anti-cyclic citrullinated peptide antibodies; DAS28 = Disease Activity Score in 28 joints; DAS44 = Disease Activity Score in 44 joints. † P = 0.015 for trend between procedures. ‡ P < 0.001 for trend between procedures. § P = 0.003 for trend between procedures. ¶ P = 0.02 for trend between procedures. # P = 0.06 for trend between procedures. ** P = 0.01 for trend between procedures.
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the PIP joint), and 10 were BN biopsies of the wrist. Of the 34 sequential biopsy procedures evaluated, 25 were performed on the large joints: 10 arthroscopic knee biopsies, 8 US-P&F biopsies (7 of the knee and 1 of the ankle), and 7 US-NB knee biopsies. Nine of the 34 sequential biopsies evaluated were from US-NB procedures of the small joints (1 of the PIP joint, 3 of the MCP joint, and 5 of the wrist) ( Table 1) . Of the 125 patients evaluated at baseline, 73 had RA, 31 had undifferentiated arthritis, 18 had psoriatic arthritis or spondyloarthritis, and 3 had juvenile idiopathic arthritis (Table 2) . When patient procedures were segregated according to biopsy technique and further according to small or large joint procedures, the numbers of patients who were seropositive for RF or ACPAs, numbers of patients with radiographic erosions, mean disease activity scores (by the DAS44 or DAS28), and mean disease duration were significantly different between the cohorts (Table 2 ). All patients included had moderately to highly active disease, with mean DAS44 or DAS28 scores ranging from 3.52 to 6.13 (Table 2) .
Histologic findings. In order to determine whether there were significant differences in synovial sampling success rates between the biopsy techniques, we examined the mean proportion of graded tissue per biopsy technique (number of graded synovial tissue fragments/total number of synovial tissue fragments) segregated into small and large joint procedures. Representative histologic images for each biopsy technique are shown in Figure 2A . For small joint procedures, a trend for BN Figure 2 . Histologic analysis of the synovial samples retrieved by each procedure. A, Representative hematoxylin and eosin-stained images of the synovial tissue retrieved by each biopsy technique. Bar = 200 lm. B, Synovial biopsy procedures were categorized according to small joint versus large joint procedures and further according to biopsy technique. Significant differences in synovial sampling success rates, total area of synovial tissue, and area of synovial tissue per graded tissue fragment were determined. C, Synovial biopsy procedures were categorized according to small joint versus large joint procedures and further according to biopsy technique. The synovitis score and number of CD20+ B cells, CD3+ T cells, and CD68+ sublining (CD68sl+) macrophages were evaluated to determine whether differences between the biopsy techniques were significant. Values are the mean (SD). P values were determined by Mann-Whitney U test or Kruskal-Wallis test for comparison of mean values, and by Fisher's exact test for comparison of proportions. P < 0.05 was considered significant. US-NB = ultrasound-guided needle biopsy; US-P&F = ultrasound-guided portal and forceps; BN = blind needle; ARTH = arthroscopy; NA = tissue not available. Color figure can be viewed in the online issue, which is available at http://onlinelibrary.wiley.com/doi/10.1002/art.40433/abstract. procedures to yield a lower proportion of graded tissue compared to US-P&F and US-NB was demonstrated (61% versus 91% and 77%, respectively; P = 0.057) (Figure 2B) . For large joint procedures, we demonstrated a significant difference in the proportion of graded tissue between techniques, with a lower proportion of graded tissue from BN procedures than from US-NB, US-P&F, and arthroscopic biopsies (73% versus 94%, 85%, and 94%, respectively; P = 0.048) ( Figure 2B ). Interestingly, in the pairwise analysis of large joint procedures, US-NB was the only procedure that did not demonstrate a significant difference in outcome compared to arthroscopy (Figure 2B) . These results suggest that in order to reliably sample synovial tissue, BN biopsy would not be favorable for either the large or small joints, and for large joints, US-NB is equivalent to arthroscopy.
We next evaluated whether there were significant differences in the area of synovial tissue sampled per biopsy technique. We evaluated differences in total mean graded synovial tissue area per biopsy technique. Furthermore, in order to account for variability in the number of biopsy fragments embedded per tissue block, we also evaluated the mean synovial tissue area per graded biopsy fragment. For small joint procedures, we found no significant differences in either the mean total graded synovial tissue area or mean synovial tissue area per graded biopsy fragment ( Figure 2B ). For large joint procedures, we demonstrated a significant difference in the mean total graded synovial tissue area between procedures (P < 0.0001), with BN procedures yielding the highest total mean area of tissue (mean 35.57 mm 2 ) and US-P&F yielding the lowest total mean area of tissue (mean 2.24 mm 2 ), compared to mean areas of 14.7 mm 2 from arthroscopic procedures and 5.67 mm 2 from US-NB procedures ( Figure 2B ). The significant difference between procedures (P < 0.0001) also persisted when tissue area was corrected for tissue fragment number (mean area per graded biopsy fragment), with a pairwise comparison identifying significant differences between BN and arthroscopic biopsies (6.11 mm 2 versus 3.66 mm 2 ; P = 0.0094) and between arthroscopic biopsies and US-P&F (3.66 mm 2 versus 1.91 mm 2 ; P = 0.02), and no significant difference between arthroscopic biopsies and US-NB (3.66 mm 2 versus 3.96 mm 2 ; P = 0.074) ( Figure 2B ). Overall, these results suggest that in order to reliably sample synovial tissue from the small joints, US-guided procedures, rather than BN procedures, would be recommended. In addition, when sampling the large joints, US-NB and arthroscopic procedures are similarly reliable at sampling synovial tissue and yielded comparable areas of synovial tissue.
In order to determine whether choice of synovial sampling technique influenced the degree of immune cell infiltration, we evaluated whether there were significant differences in the degree of immune cell infiltration or synovial pathotype between biopsy procedures. For this purpose, we compared the mean synovitis scores, mean semiquantitative scores of synovial infiltration of CD20+ B cells, CD3+ T cells, and CD68+ SL macrophages, and frequency of synovial pathotype between the techniques. We found no significant differences in any parameter between the biopsy techniques ( Figure 2C) . Importantly, these results suggest that choice of synovial sampling technique does not influence either the degree of immune cell infiltration or the synovial pathotype.
Sequential biopsy procedures. In order to determine whether the choice of biopsy procedure influenced sequential sampling success, we evaluated synovial samples from the cohort of 34 patients with paired biopsy samples retrieved at baseline and follow-up, to identify differences in biopsy techniques sequentially between sequential time points. We evaluated 1) the proportion of graded synovial tissue fragments, 2) total graded synovial tissue area, and 3) synovial tissue area per graded biopsy fragment. For small joint procedures, we evaluated 9 paired samples from US-NB procedures, and for large joints, we evaluated 7 paired samples from US-NB, 8 from US-P&F, and 10 from arthroscopic biopsy procedures. We saw no significant differences between the baseline and follow-up biopsies in terms of the proportion of graded tissue fragments, area of graded tissue, or area of graded tissue per biopsy fragment for any biopsy technique evaluated (Table 3) . These findings were observed despite the significant decline in DAS28 scores between baseline and follow-up in patients who underwent either small joint US-NB procedures (mean DAS28 5.77 at baseline versus 3.19 at follow-up; P < 0.005) or large joint arthroscopic procedures (mean DAS28 5.78 at baseline versus 3.93 at follow-up; P < 0.005). Overall, these results suggest that despite the fact that disease activity significantly diminished, the biopsy techniques evaluated demonstrate excellent reliability when sampling synovial tissue sequentially.
RNA quality and quantity. In order to determine whether there were significant differences in RNA quality and quantity between the biopsy techniques, we evaluated the total RNA yield and the RIN between biopsy procedures and between baseline and sequential biopsies. Twelve small joint US-NB procedures had paired baseline and sequential procedures for analysis. We demonstrated no significant change in RNA quantity or quality between the 2 time points (Table 4) .
For large joint biopsies, 10 arthroscopic and 10 US-NB procedures had baseline and paired sequential biopsies, and for US-P&F, 34 were available from baseline and, of these, 8 had paired sequential biopsies at follow-up. When we evaluated the large joint arthroscopic, US-NB, and US-P&F procedures, we observed significant differences in RNA quantity (mean 22.36 lg versus 6.56 lg versus 7.92 lg, respectively; P = 0.0035) and RNA quality (mean RIN 7.01 versus 5.2 versus 6.59, respectively; P = 0.013). A pairwise comparison identified arthroscopic procedures as yielding significantly higher quantities of RNA compared to US-NB or US-P&F procedures (P = 0.002 and P = 0.0014, respectively) and higher RIN values compared to US-NB (P = 0.0018), but not US-P&F (P = 0.068) ( Table 4) .
We also demonstrated a significant decline in the quantity of RNA between baseline and sequential large joint biopsy samples from arthroscopic procedures (P < 0.001), US-NB procedures (P = 0.026), and US-P&F procedures (P < 0.001), but no difference in RIN values was seen. These results suggest that all of the biopsy techniques examined yielded synovial tissue of significant quantity and quality for subsequent transcriptomic analysis (20, 21) . However, if large quantities of RNA are required, then arthroscopic rather than US-guided procedures should be performed. 
DISCUSSION
The aim of this study was to evaluate whether the choice of synovial biopsy technique could translate to significant variation in synovial tissue quality and quantity. Our primary intent was to inform recommendations for the choice of synovial sampling technique within clinical trials.
In this systematic evaluation of 125 patients undergoing synovial biopsy, we demonstrated a number of important findings. First, we found that, when performing small joint biopsies, BN biopsy is less reliable than USguided procedures for sampling synovial tissue. We also demonstrated that BN biopsy is significantly less reliable than US-guided procedures or arthroscopy when retrieving synovial tissue from large joints.
Second, when sampling synovial tissue from the large joints, US-NB procedures are as successful as arthroscopic procedures, suggesting that if reliability in synovial sampling is important in protocol design, either of these procedures may be reliably applied.
Third, we observed that small joint US-NB and large joint arthroscopy, US-NB, and US-P&F procedures are reliable for sampling synovial tissue following therapeutic intervention. Finally, we demonstrated that when retrieving samples for subsequent RNA extraction, arthroscopic large joint procedures yield a higher weight of tissue than US-P&F or US-NB, but all procedures, including small joint US-NB, yielded RNA of sufficient quantity and quality for subsequent transcriptomic studies.
The results presented within this study support the application of US-guided procedures in conjunction with arthroscopy for retrieving synovial tissue for research applications. The demonstration that minimally invasive USguided procedures can reliably sample the small joints as well as the large joints and, furthermore, do not require purchase of additional equipment (such as a small bore arthroscope) makes their inclusion in clinical trial protocols particularly attractive. Their adoption not only increases the potential pool of participants but also has the potential to reduce sampling bias because patients with a spectrum of disease severity can be recruited without being limited by the distribution of joints with active disease (e.g., the knee is often a preferred site for arthroscopy) (22) . Intuitively, it may be assumed that US-NB retrieves tissue primarily from within, rather than at the surface of, synovial tissue, but this is not supported by the results of our study, since we demonstrated that US-NB is at least equivalent to US-P&F in obtaining synovial tissue with visible lining layer.
We and other investigators (23) (24) (25) (26) have previously used the presence of the lining layer as a quality standard prior to further experimental procedures, but we should note that a consensus on quality standards for biopsy procedures has not currently been reached and remains an important working agenda of the European Synovitis Study Group. Indeed, it could be argued that for some applications, synovial tissue per se, rather than the lining layer, is important, and therefore the choice of biopsy technique may be directed by study objective. It is important to note that although the results presented herein suggest that BN biopsy is less reliable for sampling of synovial tissue, the synovial tissue area of graded samples was large. This suggests that although BN biopsy may not be the optimum choice for clinical trial design when the number of biopsy samples, rather than the biopsy area per se, is critical (7), BN biopsy would still be applicable within routine clinical practice, e.g., diagnostic sampling.
We noted that US-NB in the small and large joints and US-P&F in the large joints, consistent with that seen with arthroscopic procedures, successfully sampled tissue suitable for both histologic and molecular analyses following determination of the therapeutic response. These findings demonstrate the utility of these procedures when serial biopsies are required for examining, for example, mechanisms of therapeutic response versus nonresponse. It is important to note, however, that the RNA yield from US-guided procedures was significantly lower than that obtained from arthroscopic sampling; this should be taken into consideration if large quantities of RNA are required for subsequent experiments.
This study has some limitations. First, the retrospective design could not ensure a homogeneous patient cohort. In addition, variation in biopsy operators within and between centers may have partly influenced the results, and it was not possible to account for this within the analysis. However, it should be noted that all procedures were performed by experienced clinicians with established expertise in synovial sampling, which should have reduced this effect. We also could not control for the number of synovial fragments retrieved per procedure, although in order to address this, we corrected the total area of tissue for fragment number within our analysis.
Second, despite the demonstrated applicability of arthroscopic small joint biopsy within clinical trials (27), we were unable to identify a cohort of small joint arthroscopic biopsies with paraffin-embedded material for evaluation within this study. We were also limited to a cohort of patients who underwent biopsy of the wrist (rather than the PIP and/or MCP joints) when we examined the performance of BN biopsy in the small joints.
Finally, although our data do not demonstrate the influence of synovial biopsy procedure on the degree of synovial immune cell infiltration, previous data (28) have suggested that there was significant intrapatient variation in sublining macrophage number (although not other immune cell infiltrates) when synovial tissue was obtained by BN biopsy compared to arthroscopic biopsy. Potentially, this effect could be related to restriction in sampling regions throughout the joint when needle techniques, rather than arthroscopic or US-P&F techniques, are used. However, examining the impact of this limitation would require sampling from the same joint by multiple techniques, which was beyond the scope of this study.
Despite these limitations, this cohort is the largest reported systematic evaluation of synovial sampling technique performance. It supports the integration of US-guided methods alongside arthroscopy into clinical trial protocols requiring sequential large and small joint sampling for subsequent histologic and molecular analyses. In the future, prospective studies integrating standardized, patient-reported tolerability outcomes, adverse events, and synovial sampling success should be reported to more fully inform the debate.
